BACKGROUND Kidney disease is hard to detect at its early stage; therefore, the Kidney Disease: Improving Global Outcomes (KDIGO) 2012 guideline was developed for improving care and outcomes of patients with kidney disease. This study aimed to determine clinical outcomes from applying this guideline in a community hospital service. MATERIAL AND METHODS The patients' data were extracted from their medical records and analyzed for outcomes of using the estimated glomerular filtration rate (eGFR) and urine albumin-creatinine ratio (UACR) for detecting kidney disease. RESULTS The eGFR was utilized in 36 172 patients aged ≥18 years, and 76.86% of them had normal kidney function. The prevalence of chronic kidney disease (CKD) was 8.20%; most patients (68%) with CKD were in stages 3a and 3b. The most common causes of CKD were diabetes and hypertension. The UACR was mainly used in patients with diabetes. The percentage of patients with UACR ≥3 mg/mmol creatinine alone was significantly higher than that of patients with eGFR.
Keyphrases
- chronic kidney disease
- end stage renal disease
- healthcare
- risk factors
- small cell lung cancer
- early stage
- peritoneal dialysis
- ejection fraction
- newly diagnosed
- epidermal growth factor receptor
- mental health
- type diabetes
- tyrosine kinase
- blood pressure
- prognostic factors
- uric acid
- patient reported outcomes
- deep learning
- adverse drug
- radiation therapy
- adipose tissue
- quality improvement
- insulin resistance
- health insurance
- artificial intelligence
- lymph node